Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
快速连接

新闻

Dr. Reddy’s API team is a 2021 winner in – API Supplier of the year at Global generics & Biosimilars awards

2021

Dr. Reddy’s API team is a 2021 winner in – API Supplier of the year at Global generics & Biosimilars awards

COVID-19: Prime Minister of India's Meets Pharma leaders

2021

COVID-19: Prime Minister of India's Meets Pharma leaders

The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards

2021

The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards

The winner of the Best Indian Company in the US - Manufacturing Sector for the year 2021

2021

2021年美国制造业最佳印度公司的获胜者

Sugammadex sodium API – CADIFA approval

2021

舒更葡糖钠原料药 - 巴西卫生监督局批准的原料药档案适当性函

Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2019

2019

瑞迪博士的实验室在2019年全球仿制药和生物仿制药奖上获得“年度原料药供应商”奖

Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of ‘Excellence in Pharma: Sustainability’

2020

瑞迪博士在2020年世界医药原料展制药奖（CPhI Pharma Awards 2020）上获得了“卓越制药：可持续发展”类别的荣誉：

Deepak Sapra speaks about DRDO’s anti-covid drug 2DG

2021

迪帕克•萨普拉谈到了印度国防研究与发展组织的抗新冠病毒药物2DG

Dr.Reddy’s gearing up with Covid portfolio: Deepak Sapra, CEO of API & Services, speaks to India Today

2021

Dr.Reddy’s gearing up with Covid portfolio: Deepak Sapra, CEO of API & Services, speaks to India Today

Best Supply Chain Team of the Year - Pharma- 2021

2021

2021年度制药行业最佳供应链团队

Dr. Reddy’s Laboratories’ Anil Patni presented on HPAPIs at Manufacturing Chemist Live Virtual

2020

瑞迪博士实验室的阿尼尔•帕特尼 （Anil Patni）在《制造化学家》（Manufacturing Chemist）现场虚拟会上介绍了高效原料药（HPAPIs）

Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2020

2020

瑞迪博士实验室在2020年全球仿制药和生物仿制药奖（Global Generics & Biosimilars Awards）上获得“年度原料药供应商”奖

Dr. Reddy’s Laboratories joins Science Based Targets initiative (SBTi) and sets 2030 GHG emission targets

2020

瑞迪博士的实验室加入了科学基础目标计划（SBTi），制定了2030年的温室气体排放目标

CPhI Festival of Pharma Panel discussion: Innovation Across Borders: How Pharma and innovators are fighting Back Against COVID-19 and ways forward.

2020

世界医药原料展制药节专题讨论：跨境创新： 制药公司和创新者如何抗击新冠病毒病以及前进的道路。

CPhI Festival of Pharma Roundtable: Tackling Nitrosamine Contamination

2020

世界医药原料展制药节圆桌会议： 解决亚硝胺污染问题

Dr. Reddy’s partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a potential treatment of COVID-19

2020

瑞迪博士与富士胶片和Avigan®（法匹拉韦）全球响应援助机构（Global Response Aid）合作，Avigan®是一种潜在的新冠病毒病治疗药物

Dr. Reddy’s is featured in an article of Global Pharma Insights on “Nitrosamine contamination: pharma’s re-evaluation of its supply chain”

2020

《全球制药视野》上的一篇题为《亚硝胺污染：制药公司对其供应链的重新评估》的文章特别介绍了瑞迪博士。

Dr. Reddy’s statement on the COVID-19 pandemic

2020

瑞迪博士关于新冠病毒病大流行的报告

Certificate of Suitability (CEP) granted for Levofloxacin Hemihydrate

2020

左氧氟沙星半水合物（Levofloxacin Hemihydrate）获得欧洲药典适用性认证（CEP）

US DMF for Apalutamide - Now available

2020

阿帕鲁胺的美国药物主文件 - 现已可用

Dr. Reddy's Sustainability Report 2018-19

2020

瑞迪博士2018-19年可持续发展报告

Dr. Reddy's API Team moves into its new office in China

2019

瑞迪博士的原料药团队搬进其在中国的新办公室

X
Checked out our

API Linkedin
page yet?

Follow this page to explore how our offerings can accelerate your formulation success

Click here to visit